UNDERSTANDING THE FDA’S EXPEDITED APPROVAL PROCESSES
Education - How the FDA's approval processes differ, a investor's guide. Including Breakthrough Therapy, Accelerated Approval, Priority Review, and Fast Track.
Read nowMust Read
Obesity & PD-1: History Doesn’t Repeat But It Rhymes
The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical Submits 510(k) for Insulin Patch Pump
Modular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLatest Posts
Analysis From GBT’s EHA Abstract on Adolescent Phase 2a
Insights - Yesterday, GBT released their EHA abstract, which included some top-line data from the 900mg cohort of Part B in Phase 2a adolescent. Here are the key … Continue Reading
Read now
Bellus CEO On How They’re Challenging Merck’s $500M Cough Drug
Digital Conferences - TRANSCRIPT OF EVENT Deniel Mero Welcome to PropThink’s First-Ever Digital Conference. My name is Deniel Mero, Editor of PropThink. I will be hosting today’s event. … Continue Reading
Read nowWhat to Expect With GBT’s Upcoming Phase 3 Part A Data
Insights - Global Blood Therapeutics (GBT) Phase 3 Part A data should be out sometime in the next month (read about timeline here). GBT is expected to report … Continue Reading
Premium
Selecta’s Data Causes Selloff, But It Was Actually Immaterial
Insights - Selecta provided an update this morning for their dose escalating trial for the co-administration of:Â 1. 0.125mg/kg of SVP-rapamycin + 0.4mg/kg of pegsiticase 2. 0.15 … Continue Reading
Read now
Markets Overlooking SWKH as Company Continues Executing
Insights - SWK Holdings (SWKH) announced Q4 and full year 2017 earnings earlier this week and the company is continuing to execute on their business. We initially discussed SWK … Continue Reading
Premium